The healthcare mobile application market is anticipated to grow at a compound annual growth rate (CAGR) of 24.10% over the forecast period to reach US$32.393 billion by 2029, increasing from estimated value of US$11.004 billion in 2024....
The healthcare mobile application market is anticipated to grow at a compound annual growth rate (CAGR) of 24.10% over the forecast period to reach US$32.393 billion by 2029, increasing from estimated value of US$11.004 billion in 2024.
Digitization has caused a radical change in the way most industries operate. The expansion of a digital system also comes with a great deal of transformation into the health care system due to the increasing usage of mobile phones as well as the availability of the internet network. Because of this, the introduction and rapid uptake of mHealth technologies have primarily occurred in the last few years, propelled by the increasing utilisation of these technologies by physicians and patients. The fitness and medical categories continue to contain the majority of mobile healthcare apps.
-
Growth Drivers in the Healthcare Mobile Application Market
The e-prescription system, wearable device manufacturers, and providers of mobile health apps have all contributed to the growth of digital healthcare, which has been largely attributed to the market expansion. It is also expected that throughout time, both the public and private sectors will promote the use of health apps by highlighting their benefits for tracking and enhancing lifestyle decisions and medical conditions.
The robust growth potential of the IT industry in the healthcare sector is supported by proactive government initiatives across the globe. The healthcare industry's paradigm shift toward preventive strategies and the increase in funding for mHealth start-ups remain the main drivers of market growth. The increasing consciousness among consumers regarding fitness, wellness, and technical knowledge is a noteworthy element propelling the market expansion.
Customers are still drawn to modern healthcare apps because of their ability to provide them with up-to-date health statistics while they are on the go. In addition to the concerning rise in the prevalence of chronic illnesses and the development of new technologies, two crucial and indispensable elements for businesses to establish organized revenue channels remain a sustainable business model and strategic alliances. On the global landscape, increasing internet usage along with increasing smartphone subscriptions are equally acting as catalysts for the growth of the market.
-
Impact of Chronic Diseases on the Healthcare Mobile Application Market
The increased popularity of chronic diseases across the globe is one of the key factors responsible for the expansion of the market. Chronic diseases such as diabetes, hypertension, heart-related disorders and respiratory disorders have recorded the greatest use of these apps. For instance, the most recent estimates indicate that the prevalence rate of diabetes is 6.1% worldwide at the moment, placing it among the top 10 major causes.
-
Segmentation of the Healthcare Mobile Application Market
The healthcare mobile application market, by application type, is divided into six types- Patient engagement apps, fitness and wellness apps, medical reference apps, remote monitoring apps, electronic health record (EHR) apps, and others, The market is growing as a result of patients and healthcare professionals becoming more aware of the need to use medical applications for improved communication and patient outcomes. Moreover, it is expected that the number of new applications will increase in the market, as many of the medical applications will be made available and therefore app usage will go up.
Besides, the market has also been on the rise because of the increasing focus on healthy living, and the increased penetration of smartphones, tablets, and wearable technology to reach out to fitness applications.
The healthcare mobile application market, by deployment model, is divided into two types: On-Premise and cloud-based. The market is experiencing notable growth, primarily due to the growing utilisation of cloud-based agreements. The reason for the continuous development of this market is the need for universal healthcare services anytime and anywhere. Healthcare applications that are dependent on the Cloud allow healthcare practitioners, as well as users, to access patient information, e-health records, and other health-related services physically anywhere with an internet connection and on any device. This development is by the continuous telemedicine enhancement and remote patient monitoring.
Moreover, the demand for smart mobile phones and other mobile gadgets has changed the interactions between patients and health care systems. Mobile applications are now used every other time by patients to schedule an appointment, measure some health indicators, find information, and communicate with health professionals.
The healthcare mobile application market, by operating system, is divided into three types: iOS, Android, and others. The segment's expansion can be attributed to the widespread consumer adoption of the iOS platform along with its global reach. Moreover, the rapid growth of smartphone users coupled with the much cheaper prices of Android-based smartphones has influenced the forecast that the Android segment will grow at the highest CAGR during the forecast period.
The healthcare mobile application market, by end-user, is divided into four types: Patients, healthcare providers, fitness enthusiasts, and others. The largest end-user segment belongs to the patients. Through these apps, patients can book an appointment on their smartphones with short taps in the app without the need to physically visit the hospital or make a long phone call. Furthermore, such apps enable patients to store their test results, health histories and medical reports in one place without any struggles. Telemedicine does not fall behind in this regard. Even patients who detest long-distance travel to see their doctors appreciate the option of video consultation, which ideally cuts wait time at the hospital.
During the projected timeframe, it is anticipated that the market for healthcare mobile applications will experience remarkable growth within North America. A few significant trends and opportunities have led to a huge increase in the use of healthcare mobile applications in the USA in recent years. A primary factor contributing to this progress is the increasing ubiquity of internet-connected smartphones, which has enabled more people to have basic access to healthcare facilities. As smartphones become more prevalent, an increasing number of individuals are resorting to convenient applications for managing their health and wellness needs.
Artificial Intelligence has changed the healthcare sector in North America for the better, as long-term outcome improvement is achieved with the help of predictive analytics, personalized treatment recommendations, and accelerated processes. Machine learning algorithms assess the big data on a patient’s history to recognize patterns and forecast the development of an ailment, thus allowing timely treatment and ensuring targeted therapy.
-
Key Players in the Healthcare Mobile Application Market
The research includes several key players from the healthcare mobile application market, such as Apple Health., Nike Inc, Allscripts Healthcare Solutions, Inc, Medtronic Pl, Epic Systems Corporation, Johnson & Johnson Health and Wellness Solutions, Inc., Fitbit, Inc. (Google), Philips Healthcare, Practo Technologies Pvt. Ltd., 8fit, and MyFitnessPal.
View a sample of the report or purchase the complete study at: https://www.knowledge-sourcing.com/report/healthcare-mobile-application-marketThe Healthcare Mobile Application Market is segmented and analyzed as below:
- By Application Type
- Patient Engagement Apps
- Fitness And Wellness Apps
- Medical Reference Apps
- Remote Monitoring Apps
- Electronic Health Record (EHR) Apps
- Others
- By Deployment Model
- On-Premise
- Cloud-based
- By Operating System
- iOS
- Android
- Others
- By End-Users
- Patients
- Healthcare Providers
- Fitness Enthusiasts
- Others
- By Geography
- North America
- United States
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Others
- Asia Pacific
- Japan
- China
- India
- South Korea
- Indonesia
- Taiwan
- Others
- North America
- Healthcare Fraud Analytics Market Report
- Software as a Medical Device Market Size
- Healthcare Artificial Intelligence Market Size
Have questions?
More Press Releases
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.
Palliative Care in Oncology Market is expected to reach USD 244.1 billion by 2031
The Palliative Care in Oncology Market is witnessing a steady rise due to increasing cancer cases as well as a greater emphasis on enhancing the quality of life of patients receiving treatment. Through the management of symptoms such as pain, nausea, fatigue, and psychological distress associated with cancer, palliative care also serves as a source of support for patients during their entire disease cycle. Among the factors propelling the market are the rise in the use of palliative care at an early stage, improvements in the management of pain and therapies for supportive care, and the growth of home-based care services.
Oncology Drug Resistance Testing Market is projected to reach USD 3.41 billion in 2031 at a CAGR of 6.6 %
The oncology drug resistance testing market is expanding due to rising cancer prevalence, increasing drug resistance, and growing adoption of precision oncology. Advances in NGS-based testing, companion diagnostics, and targeted therapies, alongside FDA approvals and investments in personalized medicine, are accelerating demand for effective resistance monitoring across hospitals and clinical diagnostics worldwide.